Meeting Banner
Abstract #4340

Non-Emulsion Clinical Gadolinium/perfluorocarbon Nanoparticles for 19F MRI

Mangala Srinivas1, Houshang Amiri2, Fernando Bonetto3, Javier L. Cruz4, Eric van Dinther2, Jeanette Pots2, Arend Heerschap5, Carl Figdor1, Jolanda de Vries1

1Tumor Immunology, RUNMC, Nijmegen, Gelderland, Netherlands; 2Tumor Immunology, RUNMC, Netherlands; 3INTEC-CONICET, Argentina; 4Molecular Imaging, UMC Leiden, Leiden, Netherlands; 5Radiology, RUNMC, Nijmegen, Gelderland, Netherlands

Gadolinium has previously been used to enhance the relaxativity of perfluorocarbons for more efficient 19F MRI. However, the poor interaction between hydrophilic Gd chelates and hydrophobic perfluorocarbons is problematic. We overcome this issue using polymeric nanoparticles encapsulating both Gd chelates and perfluorocarbon, thereby forcing close interaction. These particles are synthesized using clinically-approved components, and are stable for at least 6 months. We demonstrate frequency and concentration dependence of the 19F longitudinal relaxation time. Finally, we show that labeling has minimal effect on cell function and viability when used to label primary human dendritic cells, as currently used in cancer vaccines.

Abstract PDF

Keywords

able addition affected affecting agent aging allow allows although amounts animal approved article batch batches become bone bore carbon cell cells cellular chap chelate clinical clinically close coat coil compound concentration cultured customizable developed diameter done dynamic eased effective efficacy elates employed emulsion emulsions encapsulate encapsulation enhance even ever expected extent field finally fluorine fluorocarbon forces formulation gadolinium gradient grants health highest horizontal human hydrophilic hydrophobic immunology in vivo incorporation insufficient label labels least longitudinal measured modification modulated molecular monitoring months noise often optical part particle particles pots previously prim problem protocols punt quantitative reasonable receive remained representative robe scanner scattering sign smaller stab stability stable sustained therapy tool toxic tracking trans trend trials tumor vista volume ween winter